Long-Term Follow-up of Over 600 Living Related Kidney Donors: Single-Center Experience

dc.contributor.authorSayin, Burak
dc.contributor.authorAkdur, Aydincan
dc.contributor.authorKarakaya, Emre
dc.contributor.authorSoy, Ebru H. Ayvazoglu
dc.contributor.authorHaberal, Mehmet
dc.contributor.orcIDhttps://orcid.org/0000-0002-4879-7974en_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-3462-7632en_US
dc.contributor.pubmedID35384802en_US
dc.contributor.researcherIDAAD-5466-2021en_US
dc.contributor.researcherIDAAJ-8097-2021en_US
dc.date.accessioned2023-09-19T13:08:04Z
dc.date.available2023-09-19T13:08:04Z
dc.date.issued2022
dc.description.abstractObjectives: Kidney transplant is the treatment of choice in patients with end-stage renal disease because it offers improved survival and better quality of life. Although most epidemiologic studies have suggested that living kidney donors have a minimal lifetime risk of developing end-stage renal disease, long-term complications and physiologic and psychologic sequelae resulting from donation remain unclear. Here, we examined the long-term results of living-related kidney donors who donated kidneys at the Baskent University Ankara Hospital over the past 25 years. Materials and Methods: We were able to examine 607 kidney transplant donors (mean age of 52.03 +/- 11.54 years) who were seen at our center from 1986 to 2021 and who agreed to a general health evaluation. Collected data included donor age, sex, blood type, body mass index, duration after donation, blood pressure measurements, biochemical parameters, abdominal ultrasonograph for size, structure, and renal blood flow of the solitary kidney, comorbid conditions, chronic drug use, and surgical procedures after donation. Results: Mean time after donation was 10.4 +/- 3.2 years. Twenty-four donors (3.9%) were diagnosed with diabetes and 21 (3.4%) with thyroid disease, 64 (10.5%) developed hypertension, and 48 (8.8%) developed atherosclerotic cardiovascular disease. Obesity was found to be an increasing problem in our donor population, with 174 (28.6%) developing mild to moderate obesity (body mass index >25 kg/m2). Older age, obesity, smoking, and hyperlipidemia were found to be the major and independent risk factors of both hypertension and atherosclerotic cardiovascular disease in donors. None of our donors developed endstage renal disease. Conclusions: Obesity and hypertension were the most common comorbidities that developed in our kidney donor population. Our principle is to avoid unrelated and nondirected donors because of the possible long-term complications. Unrelated donors may be desperate if a family member needs donation in the future.en_US
dc.identifier.endpage19en_US
dc.identifier.issn1304-0855en_US
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85127848480en_US
dc.identifier.startpage17en_US
dc.identifier.urihttp://hdl.handle.net/11727/10698
dc.identifier.volume20en_US
dc.identifier.wos000915505100005en_US
dc.language.isoengen_US
dc.relation.journalEXPERIMENTAL AND CLINICAL TRANSPLANTATIONen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBiochemical parametersen_US
dc.subjectComplicationsen_US
dc.subjectKidney transplanten_US
dc.subjectRelativenessen_US
dc.subjectUltrasounden_US
dc.titleLong-Term Follow-up of Over 600 Living Related Kidney Donors: Single-Center Experienceen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: